Related Experiment Video

Updated: Aug 24, 2026

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases
09:36

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases

Published on: June 28, 2019

[Progressive atrophy of the globus pallidus--case report]

Anna Bochyńska1, Wanda Lipczyńska-Łojkowska, Jerzy Kulczycki

  • 1I Kliniki Neurologicznej IPiN w Warszawie.

Neurologia I Neurochirurgia Polska
|June 4, 2004
PubMed

Insights

This case study highlights a rare diagnosis of globus pallidus atrophy (AGP) in a young woman, identified using MRI. AGP diagnosis relies on clinical symptoms and imaging due to unexplained causes and lack of specific lab tests.

Area of Science:

  • Neurology
  • Radiology
  • Pathology

Background:

  • Atrophy of the globus pallidus (AGP) is a rare neurological condition.
  • AGP is typically identified through neuropathological examination post-mortem.
  • The etiopathogenesis of AGP remains largely unexplained.

Observation:

  • A case of AGP was diagnosed in a 25-year-old woman during her lifetime.
  • Magnetic Resonance Imaging (MRI) played a crucial role in the diagnosis.
  • The patient presented with extrapyramidal symptoms including dystonia and choreoathetosis.

Findings:

  • The diagnosis of AGP in vivo is challenging due to the absence of specific laboratory markers.
  • Characteristic MRI findings, alongside clinical symptoms like muscular rigidity, support the diagnosis.
  • The case demonstrates the utility of advanced imaging in diagnosing rare neurological disorders.

Implications:

  • This case underscores the importance of considering AGP in patients with unexplained extrapyramidal symptoms and characteristic MRI findings.
  • Early clinical suspicion and advanced imaging can facilitate probable diagnosis of AGP during a patient's lifetime.
  • Current treatment for AGP is limited to symptomatic management.

More Related Videos

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy07:45

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

Published on: October 21, 2014

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...